Thanks for the response (no apologies required). You're a very
articulate advocate for some caution and controlling any
tendencies to irrational exuberance.
Not an altogether bad thing.
My feeling is that there should be enough efficacy information
(even if it's anecdotal) in the next six months,
to give us some reassurance about
the future of the company's platform.
How that influences the PPS is anyone's guess, although
my guess is that given the potential power of the technology,
a strong affirmation should result in significant increase
in valuation. Especially since it would make ADXS one of
the stars in the currently most exciting developments
in medicine.
News 
Market Data 
Discover 
